World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
59802
World Ranking
6905
National Ranking
210

Michel Marre publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michel Marre sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 665 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michel Marre D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michel Marre sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michel Marre is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine with a focus on endocrinology, diabetes, and metabolism. Their research spans multiple subfields including cardiology and cardiovascular medicine, genetics, surgery, and physiology.

Their recent publications reflect a concentration on diabetes treatment, pancreatic function, and the management of diabetes within the context of other comorbid conditions such as COVID-19. Notable papers include:

  • Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports, 2020, Diabetes & Metabolism
  • Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19, 2020, Diabetes & Metabolism
  • Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events, 2020, BMJ Open Diabetes Research & Care
  • Pathogenic variants in actionable MODY genes are associated with type 2 diabetes, 2020, Nature Metabolism
  • The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial, 2021, Diabetes Care

Michel Marre collaborates frequently with other researchers in their field. Among their most frequent co-authors are:

  • Mark Woodward
  • John Chalmers
  • Ronan Roussel
  • Samy Hadjadj
  • Stephen Harrap

Their work has been published primarily in journals specializing in diabetes and cardiovascular research. The most frequent publication venues include:

  • Diabetes Care
  • Diabetes Obesity and Metabolism
  • Diabetes
  • Cardiovascular Diabetology
  • Diabetologia

In terms of research topics, their primary focus areas cover:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Hormonal Regulation and Hypertension
  • COVID-19 Clinical Research Studies
  • Metabolism, Diabetes, and Cancer
  • Diet and metabolism studies

Michel Marre has contributed to advancing knowledge in these interconnected domains, illustrating a multidisciplinary approach to the treatment and understanding of diabetes and its related conditions. Their work integrates clinical research studies and genetic insights, supporting both medical and physiological perspectives within the broader field of medicine.

Best Publications

  • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

    Anushka Patel;Stephen MacMahon;John Chalmers

  • Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

    Elizabeth K. Speliotes;Elizabeth K. Speliotes;Cristen J. Willer;Sonja I. Berndt;Keri L. Monda

  • Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

    Benjamin F. Voight;Benjamin F. Voight;Laura J. Scott;Valgerdur Steinthorsdottir;Andrew P. Morris

  • Variation in FTO contributes to childhood obesity and severe adult obesity

    Christian Dina;David Meyre;Sophie Gallina;Emmanuelle Durand

  • Severe Hypoglycemia and Risks of Vascular Events and Death

    Sophia Zoungas;Sophia Zoungas;Anushka Patel;John Chalmers;Bastiaan E. de Galan;Bastiaan E. de Galan

  • Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

    E. K. Speliotes;C. J. Willer;S. I. Berndt;K. L. Monda

  • Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

    M. Marre;J. Shaw;M. Brändle;W. M W Bebakar

  • Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution

    Iris M. Heid;Anne U. Jackson;Joshua C. Randall;Tthomas W. Winkler

  • Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

    Toshiharu Ninomiya;Vlado Perkovic;Bastiaan E de Galan;Bastiaan E de Galan;Sophia Zoungas

  • Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes

    Sophia Zoungas;John Chalmers;Bruce Neal;Laurent Billot

  • Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations

    David Meyre;Jérôme Delplanque;Jean-Claude Chèvre;Cécile Lecoeur

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway

  • A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

    Nabila Bouatia-Naji;Amélie Bonnefond;Amélie Bonnefond;Christine Cavalcanti-Proença;Christine Cavalcanti-Proença;Thomas Sparsø

  • ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

    Lars Rydén;Peter J. Grant;Stefan D. Anker;Christian Berne

  • Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

    Z Dastani;Hivert M-F.;Hivert M-F.;N Timpson;Perry Jrb.;Perry Jrb.

  • Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

    Johan Rung;Stéphane Cauchi;Anders Albrechtsen;Lishuang Shen;Lishuang Shen

  • Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

    Simon Heller;John Buse;Miles Fisher;Satish Garg

  • Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications

    Michel Marre;Pauline Bernadet;Yves Gallois;Frederique Savagner

  • Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

    M. Marre;G. Chatellier;H. Leblanc;Tam Than Guyene

  • Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes

    Sophia Zoungas;Sophia Zoungas;Mark Woodward;Mark Woodward;Qiang Li;Mark Emmanuel Cooper

Frequent Co-Authors

Philippe Froguel
Philippe Froguel Imperial College London
Mark Woodward
Mark Woodward Imperial College London
John Chalmers
John Chalmers University of New South Wales
Sophia Zoungas
Sophia Zoungas Monash University
David Meyre
David Meyre University of Lorraine
Oluf Pedersen
Oluf Pedersen University of Copenhagen
Pavel Hamet
Pavel Hamet University of Montreal
Torben Hansen
Torben Hansen University of Copenhagen
Anushka Patel
Anushka Patel University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine doesn’t always mean becoming a doctor. If you’re considering healthcare but want an alternative route, there are a variety of flexible, online degree options available. For those who hold a non-nursing bachelor’s degree and want to pivot into nursing quickly, direct entry msn programs for non-nursing majors online are becoming increasingly popular.

If you’re looking for a less competitive entry point, check out the easiest rn program options, where requirements may be more accessible while still providing solid education. Not everyone interested in healthcare needs a clinical background; careers in medical billing and coding are in high demand, and there are accredited medical billing and coding schools with financial aid to help make the transition affordable.

For entry-level nursing, an lpn program without teas test simplifies the admission process, making it easier to get started in nursing support roles. Whichever pathway you choose, online programs make it easier than ever to balance your studies with work and family life.

Best Scientists Citing Michel Marre

Trending Scientists

Recently Published Articles